How to prevent and manage recurrent cystitis
Recurrent cystitis, also known as recurrent urinary tract infections (UTIs), is a condition defined by multiple episodes of infection in the urinary tract, generally of bacterial origin. Recurrent cystitis is characterised as either three proven separate infections in a year or two in six months. Women are more susceptible to recurrent cystitis than men, primarily due to the shorter length of the female urethra which allows bacteria easier access to the bladder.
In most cases, there is no apparent reason why people experience recurrent episodes of cystitis. In most cases the infection is caused by the bacteria E. coli, which can enter the urethra and travel up to the bladder, leading to infection. Some individuals may also have structural abnormalities in their urinary tract that make them more prone to infections.
Symptoms
The symptoms of recurrent cystitis may include:
- Frequent urination or urge to urinate
- Burning sensation during urination
- Pelvic pain or discomfort
- Low-grade fever
- Blood in urine
- Cloudy or strong-smelling urine
Prevention and management
Safe, hygiene practices are important when it comes to preventing recurrent cystitis. It’s important to wipe from front to back after using the toilet to help prevent the spread of bacteria into the urethra as well as urinating regularly.
Drinking plenty of water can help flush out bacteria from the urinary tract, so be sure to maintain adequate fluid intake. It is imperative to note that the presence of blood in the urine warrants immediate medical attention. If pain or irritation persists longer than 48 hours, consult your healthcare professional.
One possible relief for recurrent cystitis is this powerful little berry: vaccinium macrocarpon (cranberry).
Vaccinium macrocarpon may help to reduce the occurrence of cystitis however it’s important to know your cranberry types. When looking to reduce the occurrence of recurrent cystitis, look for cranberry containing proanthocyanidins (PACs), particularly PACs type A. PACs work by having an anti-adhesion effect on E. coli bacteria, which prevents the bacteria from adhering to the urinary tract wall and supports the flushing out of bacteria through urine flow. Clinical research shows that 36mg is the optimal dose of PACs required to have beneficial effect on cystitis.
At SFI Health, our Ellura product contains the recommended research dose of 36mg PACs, type A, to help reduce the occurrence of medically diagnosed cystitis. This dose was demonstrated as being statistically significant and effective to reduce the adhesion of E. coli. This study also showed that the maximum effect was shown in as little as six hours, supporting its use as an effective option.
It’s imperative for individuals experiencing recurrent cystitis to seek medical attention from a healthcare provider.
Always read the label and follow directions for use.
